Trellus Health plc (TRLS) ORD GBP0.0006
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.55p
0.50p
4.95p
£888,296
0.55p
0.50p
0.35p
n/a
0.00p (0.00%) Previous:
0.00p
37,039
n/a
100,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue ($m) | 0.11 | 0.02 |
| Profit before tax ($m) | (7.78) | (6.34) |
| Adjusted EPS (¢): | (5.00) | (4.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Trellus Health inks 12-month contract with major CRO
22 October 2025 11:16
-
Revenue up, costs down as Trellus Health nears end of cash runway
8 September 2025 13:20
-
Trellus Health signs deal with large US health plan
28 February 2024 12:51
-
Contract Signed with Leading Global CRO
22 October 2025 07:00
-
Company Update
21 October 2025 07:00
-
Interim results
8 September 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.